Functional secretome analysis reveals Annexin-A1 as important paracrine factor derived from fetal mesenchymal stem cells in hepatic regeneration von Zagoura, Dimitra, Trohatou, Ourania, Makridakis, Manousos, Kollia, Antonia, Kokla, Nikolitsa, Mokou, Marika, Psaraki, Adriana, Eliopoulos, Aristides G., Vlahou, Antonia, Roubelakis, Maria G.

Volltext

18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Large-Vessel Vasculitis During Active and Inactive Disease Stages Is Associated with the Metabolic Profil... von Palamidas, Dimitris Anastasios, Kalykakis, Georgios, Benaki, Dimitra, Chatzis, Loukas, Argyropoulou, Ourania D, Palla, Panagiota, Kollia, Antonia, Kafouris, Pavlos, Metaxas, Marinos, Goules, Andreas V, Mikros, Emmanuel, Kambas, Konstantinos, Anagnostopoulos, Constantinos D, Tzioufas, Athanasios G

Volltext

Functional secretome analysis reveals Annexin-A1 as important paracrine factor derived from fetal mesenchymal stem cells in hepatic regenerationResearch in context von Dimitra Zagoura, Ourania Trohatou, Manousos Makridakis, Antonia Kollia, Nikolitsa Kokla, Marika Mokou, Adriana Psaraki, Aristides G. Eliopoulos, Antonia Vlahou, Maria G. Roubelakis

Volltext

Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer von Gettinger, Scott N, Horn, Leora, Gandhi, Leena, Spigel, David R, Antonia, Scott J, Rizvi, Naiyer A, Powderly, John D, Heist, Rebecca S, Carvajal, Richard D, Jackman, David M, Sequist, Lecia V, Smith, David C, Leming, Philip, Carbone, David P, Pinder-Schenck, Mary C, Topalian, Suzanne L, Hodi, F Stephen, Sosman, Jeffrey A, Sznol, Mario, McDermott, David F, Pardoll, Drew M, Sankar, Vindira, Ahlers, Christoph M, Salvati, Mark, Wigginton, Jon M, Hellmann, Matthew D, Kollia, Georgia D, Gupta, Ashok K, Brahmer, Julie R

Volltext

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer von Topalian, Suzanne L, Hodi, F. Stephen, Brahmer, Julie R, Gettinger, Scott N, Smith, David C, McDermott, David F, Powderly, John D, Carvajal, Richard D, Sosman, Jeffrey A, Atkins, Michael B, Leming, Philip D, Spigel, David R, Antonia, Scott J, Horn, Leora, Drake, Charles G, Pardoll, Drew M, Chen, Lieping, Sharfman, William H, Anders, Robert A, Taube, Janis M, McMiller, Tracee L, Xu, Haiying, Korman, Alan J, Jure-Kunkel, Maria, Agrawal, Shruti, McDonald, Daniel, Kollia, Georgia D, Gupta, Ashok, Wigginton, Jon M, Sznol, Mario

Volltext

Effects of Enzyme Replacement Therapy on Cardiac MRI Findings in Fabry Disease: A Systematic Review and Meta-Analysis von Figliozzi, Stefano, Kollia, Eleni, Simistiras, Alexandros, Camporeale, Antonia, Stankowski, Kamil, Masci, Pier Giorgio, Mavraganis, George, Lombardi, Massimo, Condorelli, Gianluigi, Francone, Marco, Pieroni, Maurizio, Georgiopoulos, Georgios

Volltext

Long-term Survival, Clinical Activity, and Safety of Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) in Patients (Pts) With Advanced Non-Small Cell Lung Cancer (NSCLC) von Gettinger, S.N, Horn, L, Gandhi, L, Spigel, D.R, Antonia, S.J, Rizvi, N.A, Powderly, J.D, Heist, R.S, Carvajal, R.D, Jackman, D.M, Sequist, L.V, Smith, D.C, Leming, P.D, Topalian, S.L, Hodi, F, Sznol, M, Harbison, C.T, Kollia, G.D, Brahmer, J.R

Volltext

Long-term Survival, Clinical Activity, and Safety of Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) in Patients (Pts) With Advanced Non-Small Cell Lung Cancer (NSCLC): Metastatic Non-... von Gettinger, S.N., Horn, L., Gandhi, L., Spigel, D.R., Antonia, S.J., Rizvi, N.A., Powderly, J.D., Heist, R.S., Carvajal, R.D., Jackman, D.M., Sequist, L.V., Smith, D.C., Leming, P.D., Topalian, S.L., Hodi, F., Sznol, M., Harbison, C.T., Kollia, G.D., Brahmer, J.R.

Volltext

Clinical Activity and Safety of Anti-Programmed Death-1 (PD-1) (BMS-936558/MDX-1106/ONO-4538) in Patients (PTS) with Advanced Non-Small Cell Lung Cancer (NSCLC) von Gettinger, S., Horn, L., Antonia, S.J., Spigel, D., Gandhi, L., Sequist, L.V., Wigginton, J.M., Kollia, G., Gupta, A., Brahmer, J.R.

Volltext

Clinical activity and safety of anti-PD1 (BMS-936558, MDX-1106) in patients with advanced non-small-cell lung cancer (NSCLC) von Brahmer, Julie R., Horn, Leora, Antonia, Scott, Spigel, David R., Gandhi, Leena, Sequist, Lecia V., Wigginton, Jon, McDonald, Dan, Kollia, Georgia, Gupta, Ashok Kumar, Gettinger, Scott N.

Volltext

Survival and long-term follow-up of the phase I trial of nivolumab (Anti-PD-1; BMS-936558; ONO-4538) in patients (pts) with previously treated advanced non-small cell lung cancer (... von Brahmer, Julie R., Horn, Leora, Antonia, Scott J., Spigel, David R., Gandhi, Leena, Sequist, Lecia V., Sankar, Vindira, Ahlers, Christoph Matthias, Wigginton, Jon M., Kollia, Georgia, Gupta, Ashok Kumar, Gettinger, Scott N.

Volltext

Nivolumab (anti-PD-1, BMS-936558, ONO-4538) in patients (pts) with advanced non-small-cell lung cancer (NSCLC): Survival and clinical activity by subgroup analysis von Brahmer, Julie R., Horn, Leora, Gandhi, Leena, Spigel, David R., Antonia, Scott Joseph, Rizvi, Naiyer A., Powderly, John D., Heist, Rebecca Suk, Carvajal, Richard D., Jackman, David Michael, Sequist, Lecia V., Smith, David C., Leming, Philip D., Topalian, Suzanne Louise, Hodi, F. Stephen, Sznol, Mario, Harbison, Christopher, Kollia, Georgia, Gupta, Ashok Kumar, Gettinger, Scott N.

Volltext

Nivolumab (anti-PD-1; BMS-936558; ONO-4538) in patients with advanced solid tumors: Survival and long-term safety in a phase I trial von Topalian, Suzanne Louise, Sznol, Mario, Brahmer, Julie R., McDermott, David F., Smith, David C., Gettinger, Scott N., Taube, Janis M., Drake, Charles G., Pardoll, Drew M., Powderly, John D., Carvajal, Richard D., Sosman, Jeffrey Alan, Atkins, Michael B., Antonia, Scott J., Spigel, David R., Lawrence, Donald P., Kollia, Georgia, Gupta, Ashok Kumar, Wigginton, Jon M., Hodi, F. Stephen

Volltext

Anti-PD-1 (BMS-936558, MDX-1106) in patients with advanced solid tumors: Clinical activity, safety, and a potential biomarker for response von Topalian, Suzanne Louise, Brahmer, Julie R., Hodi, F. Stephen, McDermott, David F., Smith, David C., Gettinger, Scott N., Taube, Janis M., Drake, Charles G., Pardoll, Drew M., Antonia, Scott, Spigel, David R., Atkins, Michael B., Lawrence, Donald P., McDonald, Dan, Jure-Kunkel, Maria, Korman, Alan, Kollia, Georgia, Gupta, Ashok Kumar, Wigginton, Jon, Sznol, Mario

Volltext

Anti-PD-1 (BMS-936558, MDX-1106) in patients with advanced solid tumors: Clinical activity, safety, and a potential biomarker for response von Topalian, Suzanne Louise, Brahmer, Julie R., Hodi, F. Stephen, McDermott, David F., Smith, David C., Gettinger, Scott N., Taube, Janis M., Drake, Charles G., Pardoll, Drew M., Antonia, Scott, Spigel, David R., Atkins, Michael B., Lawrence, Donald P., McDonald, Dan, Jure-Kunkel, Maria, Korman, Alan, Kollia, Georgia, Gupta, Ashok Kumar, Wigginton, Jon, Sznol, Mario

Volltext